HT
MRNA icon

HAP Trading’s Moderna MRNA Stock Holding History

HAP Trading’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.1K Sell
28,900
-41,400
-59% -$1.15M ﹤0.01% 793
2025
Q2 		$13.9K Buy
70,300
+2,600
+4% +$68.5K ﹤0.01% 630
2025
Q1 		$102K Buy
67,700
+54,000
+394% +$1.92M 0.01% 393
2024
Q4 		$7.84K Sell
13,700
-36,300
-73% -$1.73M ﹤0.01% 631
2024
Q3 		$79.5K Buy
+50,000
New +$4.59M 0.01% 424
2023
Q4 		– Sell
-16,400
Closed -$7.58K – 1107
2023
Q3 		$7.58K Buy
16,400
+5,100
+45% +$569K ﹤0.01% 819
2023
Q2 		$21.4K Buy
+11,300
New +$1.51M ﹤0.01% 689
2023
Q1 		– Sell
-82,200
Closed -$622K – 1505
2022
Q4 		$622K Buy
82,200
+36,300
+79% +$5.94M 0.06% 258
2022
Q3 		$149K Sell
45,900
-4,800
-9% -$728K 0.01% 691
2022
Q2 		$550K Sell
50,700
-12,500
-20% -$1.79M 0.03% 420
2022
Q1 		$1.29M Sell
63,200
-21,600
-25% -$3.64M 0.05% 291
2021
Q4 		$3.35M Buy
84,800
+5,500
+7% +$1.61M 0.09% 194
2021
Q3 		$8.09M Buy
79,300
+36,900
+87% +$13.6M 0.26% 82
2021
Q2 		$3.41M Buy
42,400
+3,400
+9% +$608K 0.11% 184
2021
Q1 		$1.09M Sell
39,000
-46,900
-55% -$6.8M 0.06% 305
2020
Q4 		$1.82M Buy
85,900
+26,200
+44% +$2.65M 0.05% 285
2020
Q3 		$863K Sell
59,700
-145,100
-71% -$10.1M 0.04% 293
2020
Q2 		$1.53M Buy
204,800
+167,500
+449% +$9.17M 0.08% 212
2020
Q1 		$237K Buy
+37,300
New +$858K 0.02% 504

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

HAP Trading's MRNA Position: Q1 2024 in Review

HAP Trading sold out of Moderna (MRNA) in Q1 2024, closing a stake of 14,736 shares — an estimated $1.49M sold.

HAP Trading first reported a position in MRNA in Q3 2019 and held it in 9 quarters. The position peaked at $10.4M in Q2 2021. 903 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • HAP Trading reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • HAP Trading sold 14,736 Moderna shares in Q1 2024, an estimated $1.49M.
  • HAP Trading first reported a position in Moderna in Q3 2019 and held it in 9 quarters.
  • HAP Trading's Moderna position peaked at $10.4M in Q2 2021.
  • 903 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on HAP Trading's 13F filing for Q1 2024, filed 13 May 2024.